Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 0 | 1,707 | 11,424 | 0 | 267 |
| Gross Profit | N/A | 1,707 | 11,424 | N/A | 267 |
| Operating Expenses | 132,421 | 108,043 | 100,102 | 84,862 | 89,754 |
| Operating Income | -132,421 | -106,336 | -88,678 | -84,862 | -89,487 |
| Other Income | -3,259 | 5,249 | 1,342 | 2,003 | 2,832 |
| Pre-tax Income | -135,680 | -101,087 | -87,336 | -82,859 | -86,655 |
| Net Income Continuous | -135,680 | -101,087 | -87,336 | -82,859 | -86,655 |
| Net Income | $-135,680 | $-101,087 | $-87,336 | $-82,859 | $-86,655 |
| EPS Basic Total Ops | -2.67 | -2.09 | -1.96 | -1.89 | -2.02 |
| EPS Basic Continuous Ops | -2.67 | -2.09 | -1.96 | -1.89 | -2.02 |
| EPS Diluted Total Ops | -2.67 | -2.09 | -1.96 | -1.89 | -2.02 |
| EPS Diluted Continuous Ops | -2.67 | -2.09 | -1.96 | -1.89 | -2.02 |
| EBITDA(a) | $-131,126 | $-105,927 | $-88,510 | $-85,078 | $-89,881 |